VFQY - ETF AI Analysis
Top Page
Vanguard U.S. Quality Factor ETF (VFQY)
VFQY, the Vanguard U.S. Quality Factor ETF, appears to be a solid fund built around financially strong companies, with leaders like Apple, Ross Stores, Cintas, and Lam Research boosting its rating through robust profitability, positive earnings calls, and generally supportive technical trends. These strengths are partly offset by weaker names such as 3M and SanDisk, where leverage, profitability, and valuation concerns weigh on their outlook. A key risk is that several holdings show signs of high or premium valuations and, in some cases, overbought technical conditions, which could make the fund more sensitive to market pullbacks.
VFQY vs. SPDR S&P 500 ETF (SPY)
- AUM
- 524.71M
- Region
- North America
- Expense Ratio
- 0.13%
- Beta
- 0.88
- Issuer
- Vanguard
- Inception Date
- Feb 13, 2018
- Dividend Yield
- 1.01%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
VFQY Summary
Vanguard U.S. Quality Factor ETF (VFQY) is a fund that invests in a wide range of U.S. companies chosen for their strong business fundamentals, such as steady profits and lower debt. It doesn’t track a single index, but follows a “quality” theme across the total U.S. stock market, with holdings in technology, industrials, financials, and more. Well-known companies in the fund include Apple and Costco. Investors might consider VFQY for long-term growth and diversification into higher-quality stocks. A key risk is that it still moves with the overall stock market, so its value can go up and down.
How much will it cost me?
VFQY has an expense ratio of 0.13%, which means you’ll pay about $1.30 per year for every $1,000 invested. This cost is slightly higher than the cheapest broad index ETFs because VFQY is a factor-based, actively managed strategy that selects higher-quality companies rather than simply tracking a standard market index.
What would affect this ETF?
VFQY focuses on high-quality U.S. companies across technology, industrials, financials, and consumer sectors, so it could benefit if the U.S. economy grows steadily, consumer spending remains strong, and well-managed firms like Apple, Costco, and Eli Lilly continue to perform well. On the downside, rising interest rates, a U.S. recession, sector-specific challenges in areas like technology or financials, or new regulations affecting major holdings could hurt the fund’s future returns.
VFQY Top 10 Holdings
VFQY leans into high-quality U.S. names, with tech and health care doing much of the heavy lifting. Apple and Texas Instruments have been steadily rising, giving the fund a solid boost from the Big Tech and semiconductor theme. Eli Lilly and Gilead add a strong health care backbone, with their gains helping smooth out bumps elsewhere. On the flip side, Fortinet’s mixed, recently lagging action and Spotify’s choppy performance have been mild drags. Overall, the ETF is U.S.-centric, diversified, but still tilted toward quality growth stories.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 GILD | Gilead Sciences | 1.58% | $8.26M | $211.64B | 44.11% | 78Outperform |
 FTNT | Fortinet | 1.09% | $5.73M | $99.84B | 61.62% | 71Outperform |
 CTAS | Cintas | 1.37% | $7.18M | $87.29B | 19.48% | 79Outperform |
 MMM | 3M | 1.34% | $7.02M | $90.09B | 4.74% | 59Neutral |
 COST | Costco | 1.29% | $6.76M | $448.57B | 10.01% | 72Outperform |
 AAPL | Apple | 1.29% | $6.76M | $5.03T | 26.98% | 79Outperform |
 TXN | Texas Instruments | 1.24% | $6.51M | $274.90B | 87.43% | 78Outperform |
 SPOT | Spotify | 1.24% | $6.51M | $122.18B | -9.63% | 66Neutral |
 LLY | Eli Lilly & Co | 1.25% | $6.55M | $1.33T | 67.86% | 72Outperform |
 TJX | TJX Companies | 1.16% | $6.08M | $154.34B | -1.39% | 79Outperform |
VFQY Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VFQY, the sentiment is Positive. The current price of 175.93 is above the 20-day moving average (MA) of 175.21, above the 50-day MA of 174.34, and above the 200-day MA of 164.50, indicating a bullish trend. The MACD of 1.04 indicates Negative momentum. The RSI at 53.10 is Neutral, neither overbought nor oversold. The STOCH value of 64.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VFQY.
VFQY Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| VFQY | $175.93 | $191.00(8.57% Upside) | $524.71M | 0.13% | 72Outperform |
 SEUS | $25.65 | $30.86(20.31% Upside) | $946.37M | 0.30% | 73Outperform |
 BGDV | $31.27 | $37.14(18.78% Upside) | $877.55M | 0.45% | 74Outperform |
 AAUB | $49.94 | $60.71(21.58% Upside) | $845.51M | 0.10% | 66Neutral |
 AVTM | $53.85 | $64.50(19.78% Upside) | $779.89M | 0.22% | 60Neutral |
 XCHG | $27.13 | $33.33(22.87% Upside) | $716.83M | 0.50% | 70Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VFQY | Vanguard U.S. Quality Factor ETF | 175.93 | 27.29 | 18.36% | |
| SEUS | SEI QiM U.S. Equity Factor Allocation Active ETF | 25.65 | 0.39 | 1.53% | |
| BGDV | Bahl & Gaynor Dividend ETF | 31.27 | 5.03 | 19.16% | |
| AAUB | Alpha Architect US Equity 4 ETF | 49.94 | 0.45 | 0.91% | |
| AVTM | Avantis Total Equity Markets ETF | 53.85 | 4.21 | 8.47% | |
| XCHG | AB US Equity ETF | 27.13 | 2.28 | 9.18% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.